Search This Blog

Saturday, August 31, 2019

Abiomed Impella® SmartAssist Platform Launches at Euro Cardiology Society

Abiomed announces today that the Impella CP® with SmartAssist technology, which is designed to improve patient outcomes with advanced algorithms and simplified patient management, will be commercially available in Europe beginning at the European Society of Cardiology (ESC) Congress 2019 through a controlled roll out process at select sites. The majority of Impella CP heart pumps in Europe will be transitioned to SmartAssist over the next 12 months.
The new Impella CP heart pump features a fiber optic sensor, optimally positioned to measure the placement signal in the aorta, identify pump placement and enable repositioning without the use of imaging. (Graphic: Abiomed)
The new Impella CP heart pump features a fiber optic sensor, optimally positioned to measure the placement signal in the aorta, identify pump placement and enable repositioning without the use of imaging. (Graphic: Abiomed)
The new Impella CP heart pump features a fiber optic sensor, optimally positioned to measure the placement signal in the aorta, identify pump placement and enable repositioning without the use of imaging. The advanced sensors also enable the calculation and display of additional physiological data on the Automated Impella Controller. These advances to the Impella forward-flow heart pump technologies and software are designed to improve ease-of-use and patient management to improve both survival and heart recovery:
Weaning Algorithms to Optimize Survival and Native Heart Recovery:
  • Real-time displays of critical hemodynamic metrics indicative of left ventricular end-diastolic pressure (LVEDP), mean arterial pressure (MAP), and cardiac power output (CPO). Impella CP with SmartAssist is the only mechanical circulatory support device that calculates and displays pressure signals indicative of LVEDP, MAP and CPO.
Easier Management and Repositioning:
  • SmartAssist sensor allows for precise positioning in the aorta and left ventricle and repositioning in the ICU without the need for catheterization lab or ultrasound imaging1.
Greater Hemodynamic Support:
  • Allows for sustained peak flows of up to 4.3L/minute (>85% of a normal cardiac cycle).
Faster, Simplified Impella Console Set Up:
  • Less than 90 seconds with fewer connections and reduced steps.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.